2017-03-06,IPI-549 Featured At 15th International Congress On Targeted Anticancer Therapies
2017-03-02,Infinity Announces Presentation On IPI-549 At AACR Annual Meeting
2017-02-28,Infinity Announces The Date Of Its Full-Year 2016 Financial Results Conference Call And Webcast
2017-02-27,Infinity To Present At 37th Annual Cowen And Company Healthcare Conference
2017-02-13,Infinity Announces Promotion Of Jeffery Kutok, M.D., Ph.D. To Chief Scientific Officer
2017-02-06,Infinity To Present At The 2017 BIO CEO & Investor Conference
2017-01-20,Infinity Presents Preclinical Data And Phase 1 Clinical Data On IPI-549 At PI3K Keystone Symposia Conference
2017-01-11,Dow Needs to Hit 20K to Shake Things Up
2017-01-09,Infinity Provides 2017 Goals And Financial Guidance
2017-01-08,Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy
2017-01-05,Infinity To Present At 35th Annual J.P. Morgan Annual Healthcare Conference
2017-01-04,Infinity Announces Organizational Changes
2016-12-21,5 Stocks Insiders Love Right Now
2016-11-11,Notable Friday Option Activity: INFI, RSO, P
2016-11-09,Infinity Announces Second Publication On PI3K-Gamma In Nature
2016-11-09,Bristol-Myers Squibb And Infinity Pharmaceuticals Announce Clinical Collaboration To Evaluate Opdivo (Nivolumab) In Combination With IPI-549 In Advanced Solid Tumors
2016-11-09,Bristol-Myers Squibb And Infinity Pharmaceuticals Announce Clinical Collaboration To Evaluate Opdivo (nivolumab) In Combination With IPI-549 In Advanced Solid Tumors
2016-11-04,Infinity Moves The Date Of Its Third Quarter 2016 Financial Results Conference Call And Webcast
2016-11-02,Verastem Licenses Duvelisib From Infinity Pharmaceuticals
2016-11-02,Verastem Licenses Duvelisib From Infinity Pharmaceuticals
2016-10-31,Infinity Announces The Date Of Its Third Quarter 2016 Financial Results Conference Call And Webcast
2016-10-26,Short Interest Jumps 24.6% For INFI
2016-09-27,Infinity Pharmaceuticals (INFI) Stock Rises on 'Favorable' Cancer Drug Trial Results
2016-09-26,Infinity Presents Initial Clinical And New Preclinical Data On IPI-549 At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
2016-09-19,Infinity Announces Publication On PI3K-Gamma In Nature
2016-09-06,Infinity Announces Presentations On IPI-549 At Upcoming Immuno-Oncology Meeting
2016-08-02,Infinity Announces The Date Of Its Second Quarter 2016 Financial Results Conference Call And Webcast
2016-06-28,Infinity Regains Worldwide Rights To Duvelisib Following Mutual Agreement With AbbVie To End Collaboration
2016-06-26,7 Stocks Under $10 to Trade for Big Post-Brexit Gains
2016-06-17,Lifshitz & Miller Law Firm Announces Investigation Of CBL & Associates Properties, Inc., Eagle Pharmaceuticals, Inc., HCP, Inc., Immunomedics, Inc., Infinity Pharmaceuticals Inc., Neovasc, Inc., And Unilife Corporation
2016-06-16,Infinity Pharmaceuticals (INFI) Highlighted As Weak On High Volume
2016-06-15,Infinity Pharmaceuticals Faces Downgrades as Drug Results Disappoint
2016-06-15,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Infinity Pharmaceuticals Inc. (INFI)
2016-06-15,Infinity Pharmaceuticals Cannot Cure Downgrades After Drug Study
2016-06-15,Strong On High Volume: Infinity Pharmaceuticals (INFI)
2016-06-14,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Into Possible Securities Fraud Violations By Certain Officers And Directors Of Infinity Pharmaceuticals, Inc.
2016-06-14,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Infinity Pharmaceuticals Inc. - INFI
2016-06-14,Why Infinity Pharmaceuticals (INFI) Stock Is Tanking Today
2016-06-14,Morning Movers: BIDU, WGP, NERV, INFI
2016-06-14,Infinity Reports Topline Results From DYNAMO™, A Phase 2 Monotherapy Study Of Investigational Molecule Duvelisib In Refractory Indolent Non-Hodgkin Lymphoma
2016-06-01,Infinity Announces Launch Of Disease Awareness Campaign For Hematologic Malignancies
2016-05-31,Infinity To Participate In Three June Investor Conferences
2016-05-19,Infinity Announces Presentations On Investigational Development Candidates, Duvelisib And IPI-549, At Upcoming EHA And ASCO Meetings
2016-05-05,Infinity Pharmaceuticals is Now Oversold (INFI)
2016-04-27,Infinity To Participate In Three May Investor Conferences
2016-04-20,Infinity Announces The Date Of Its First Quarter 2016 Financial Results Conference Call And Webcast
2016-04-18,IPI-549 Alters The Immune-Suppressive Microenvironment And Enhances The Activity Of Checkpoint Inhibitors In Preclinical Models
2016-04-17,8 Stocks Under $10 to Trade for Big Gains
2016-04-13,Short Interest Falls 21.2% For INFI
2016-04-06,Trade-Ideas: Infinity Pharmaceuticals (INFI) Is Today's Strong On High Relative Volume Stock
2016-03-14,Strong On High Volume: Infinity Pharmaceuticals (INFI)
2016-02-17,Infinity To Participate In Two Upcoming Investor Conferences
2016-02-09,Infinity Announces The Date Of Its Full-Year 2015 Financial Results Conference Call And Webcast
2016-02-08,Infinity Pharmaceuticals Enters Oversold Territory (INFI)
2016-01-14,Infinity Pharmaceuticals Stock Sees Short Interest Fall 27.8%
2016-01-11,Infinity Pharmaceuticals Is Now Oversold (INFI)
2016-01-11,Infinity Provides Key 2016 Goals And Financial Guidance
2016-01-06,Infinity To Present At J.P. Morgan Annual Healthcare Conference
2016-01-05,Infinity Pharmaceuticals (INFI) Is Today's Strong On High Volume Stock
2015-11-24,First Week of July 2016 Options Trading For Infinity Pharmaceuticals (INFI)
2015-11-17,Trade-Ideas: Infinity Pharmaceuticals (INFI) Is Today's Strong On High Relative Volume Stock
2015-11-17,Infinity Announces Completion Of Target Enrollment In DUO™, A Phase 3 Study Evaluating Duvelisib In Chronic Lymphocytic Leukemia
2015-11-12,Infinity Pharmaceuticals (INFI) Weak On High Volume
2015-10-28,Infinity Announces The Date Of Its Third Quarter 2015 Financial Results Conference Call And Webcast
2015-10-21,First Week of INFI December 18th Options Trading
2015-10-06,Infinity Pharmaceuticals (INFI) Weak On High Volume Today
2015-10-06,Infinity To Provide Update On Duvelisib And Immuno-Oncology Development Candidate IPI-549 During 2015 Research And Development Day
2015-09-30,Infinity Announces Enrollment Of 120th Patient In Phase 2 DYNAMO™ Study Evaluating Duvelisib In Indolent Non-Hodgkin Lymphoma
2015-09-29,Infinity Pharmaceuticals (INFI) Flagged As Strong On High Volume
2015-09-24,Interesting INFI Put And Call Options For November 20th
2015-09-23,Commit To Buy Infinity Pharmaceuticals At $9, Earn 26.7% Annualized Using Options
2015-09-22,Infinity To Host 2015 Research & Development Day
2015-09-21,4 Stocks Rising on Unusual Volume
2015-09-21,Trade-Ideas: Infinity Pharmaceuticals (INFI) Is Today's Strong On High Relative Volume Stock
2015-09-18,Infinity Expands Pipeline With Addition Of IPI-549, An Immuno-Oncology Development Candidate For The Treatment Of Solid Tumors
2015-09-18,5 Stocks Ready for Breakouts
2015-09-02,Infinity To Participate In Three Conferences In September
2015-08-21,Trade-Ideas: Infinity Pharmaceuticals (INFI) Is Today's Strong On High Relative Volume Stock
2015-08-06,Infinity Provides Company Update And Reports Second Quarter 2015 Financial Results
2015-07-30,Infinity Announces The Date Of Its Second Quarter 2015 Financial Results Conference Call And Webcast
2015-07-21,Infinity Pharmaceuticals Enters Oversold Territory (INFI)
2015-07-21,Infinity To Participate In Two Upcoming Conferences
2015-07-01,10 Worst Biotech Stocks in the NASDAQ
2015-06-25,Commit To Purchase Infinity Pharmaceuticals At $9, Earn 14.9% Annualized Using Options
2015-06-09,RSI Alert: Infinity Pharmaceuticals (INFI) Now Oversold
2015-05-31,Infinity Reports Phase 1 Data Showing Clinical Activity Of Duvelisib In Treatment-Naïve Patients With Chronic Lymphocytic Leukemia
2015-05-27,Infinity To Participate In Three Investor Conferences In June
2015-05-26,Infinity Reports Preclinical Data For Duvelisib Demonstrating Synergy With Standard-of-Care Therapies And Emerging Agents In Development For The Treatment Of Hematologic Malignancies
2015-05-18,Strong On High Volume: Infinity Pharmaceuticals (INFI)
2015-05-14,Today's Weak On High Volume Stock: Infinity Pharmaceuticals (INFI)
2015-05-13,Infinity Announces New Data For Duvelisib To Be Presented At The 2015 American Society Of Clinical Oncology Annual Meeting
2015-05-06,Oversold Conditions For Infinity Pharmaceuticals (INFI)
2015-05-06,Infinity Reports First Quarter 2015 Financial Results And Recent Corporate Developments
2015-04-30,Infinity To Participate In Three Conferences In May
2015-04-22,Infinity Announces The Date Of Its First Quarter 2015 Financial Results Conference Call And Webcast
2015-04-20,Infinity Reports Preclinical Data For Duvelisib In Combination With Venetoclax At The 2015 American Association For Cancer Research Annual Meeting
2015-04-14,Sujay Kango, Executive Vice President, Chief Commercial Officer (Photo: Business Wire)
2015-04-01,Notable Two Hundred Day Moving Average Cross - INFI
2015-03-31,Infinity Exercises Option To Buy Out All Future Royalty Obligations To Takeda For Duvelisib Sales In Oncology
2015-03-25,Commit To Purchase Infinity Pharmaceuticals At $10, Earn 7.4% Annualized Using Options
2015-03-02,Infinity Pharmaceuticals (INFI) Downgraded From Hold to Sell
2015-02-27,Ratings Changes Today
2015-02-24,Infinity Provides Company Update And Reports Full-Year 2014 Financial Results
2015-02-18,Infinity To Present At The RBC Capital Markets 2015 Healthcare Conference
2015-02-10,Infinity Announces The Date Of Its Full-Year 2014 Financial Results Conference Call And Webcast
2015-01-12,Infinity Provides Key 2015 Goals And Financial Guidance
2015-01-08,Infinity Reports Topline Results From Phase 2 Study Of Duvelisib In Rheumatoid Arthritis
2015-01-05,Infinity To Present At J.P. Morgan 33rd Annual Healthcare Conference
2014-12-24,Commit To Buy Infinity Pharmaceuticals At $10, Earn 10% Using Options
2014-12-09,Infinity Reports New Results From Phase 1 Study Of Investigational Oncology Compound Duvelisib At The American Society Of Hematology Annual Meeting
2014-12-08,Infinity Reports New Translational Research And Updated Phase 1 Data Of Investigational Oncology Compound Duvelisib At American Society Of Hematology Annual Meeting
2014-11-26,Infinity Pharmaceuticals Stock Sees Short Interest Fall 18%
2014-11-26,Infinity Pharmaceuticals (INFI) Is Today's Strong On High Volume Stock
2014-11-24,Infinity To Present At The Deutsche Bank Securities 2014 BioFEST Conference
2014-11-14,Infinity Pharmaceuticals (INFI) Is Strong On High Volume Today
2014-11-14,Infinity Pharmaceuticals (INFI) Upgraded From Sell to Hold
2014-11-13,Ratings Changes Today
2014-11-06,Infinity Reports Third Quarter 2014 Financial Results And Provides Company Update
2014-11-06,Infinity Announces Clinical And Preclincal Data For Duvelisib To Be Presented At ASH 2014 Annual Meeting
2014-10-30,Infinity To Participate In Four Conferences In November
2014-10-23,Infinity Announces The Date Of Its Third Quarter 2014 Financial Results Conference Call And Webcast
2014-10-16,Infinity Reports Topline Data From Phase 2a Exploratory Study Of Duvelisib In Patients With Mild, Allergic Asthma
2014-09-24,First Week Of INFI November 22nd Options Trading
2014-09-03,Why Infinity Pharmaceuticals (INFI) Stock Is Soaring Today
2014-09-03,Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership
2014-09-03,Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology
2014-09-03,Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology
2014-09-03,Infinity Enters Into Master Clinical Supply Agreement And Material Transfer Agreement With Roche
2014-08-27,Infinity Pharmaceuticals Stock Sees Short Interest Move 13% Lower
2014-08-27,Infinity To Participate In Two Conferences In September
2014-08-12,Infinity Pharmaceuticals Stock Sees Short Interest Decrease By 11.6%
2014-08-11,3 Stocks Breaking Out With Unusual Volume
2014-08-06,3 Stocks Under $10 Making Big Moves
2014-08-05,Infinity Reports Second Quarter 2014 Financial Results And Provides Company Update
2014-08-04,Infinity Amends PI3K-Delta, Gamma Agreement With Millennium
2014-08-04,Interesting INFI Put And Call Options For August 16th
2014-07-31,Relative Strength Alert For Infinity Pharmaceuticals
2014-07-24,Infinity Announces The Date Of Its Second Quarter 2014 Financial Results Conference Call And Webcast
2014-07-22,Infinity To Participate In The BMO Capital Markets 3RD Annual Biotech Corporate Access Day
2014-06-03,Infinity To Present At The Goldman Sachs 35th Annual Global Healthcare Conference
2014-05-30,'Fast Money' Recap: What's On? How About Netflix Stock?
2014-05-27,Infinity To Participate In Four Conferences In June
2014-05-06,Infinity Reports First Quarter 2014 Financial Results And Provides Company Update
2014-04-30,Infinity To Participate In 3 Upcoming Conferences
2014-04-25,RSI Alert: Infinity Pharmaceuticals (INFI) Now Oversold
2014-04-24,Infinity Announces The Date Of Its First Quarter 2014 Financial Results Conference Call And Webcast
2014-04-03,Infinity Pharmaceuticals Enters Oversold Territory (INFI)
2014-03-10,Infinity Appoints Two Experienced Life Science Leaders to Its Board of Directors
2014-03-03,Infinity To Present At The Upcoming Bernstein Emerging Biotech Conference
2014-02-25,Infinity Provides Company Update And Reports Full-Year 2013 Financial Results
2014-02-19,Infinity To Participate In 3 Upcoming Conferences
2014-02-11,Infinity Announces The Date Of Its Full-Year 2013 Financial Results Conference Call And Webcast
2014-02-04,Infinity Announces Promotion Of David A. Roth To Chief Medical Officer
2014-01-23,Infinity Reports Phase 1 Data Of IPI-145 At Sixth Annual T-Cell Lymphoma Forum
2014-01-13,Infinity Provides Key 2014 Goals And Financial Guidance
2014-01-06,Infinity To Present At J.P. Morgan Annual Healthcare Conference
2013-12-30,The Billion-Dollar Biotech Club: Speculation Trumped Risk
2013-12-18,Why Investors Are Writing Off Infinity Pharma
2013-12-17,Commit To Purchase Infinity Pharmaceuticals At $8, Earn 13.8% Using Options
2013-12-08,Infinity Reports Updated Phase 1 Data Showing Encouraging Clinical Activity Of IPI-145 In Chronic Lymphocytic Leukemia And T-Cell Lymphoma At ASH Annual Meeting
2013-12-07,Infinity Reports Updated Phase 1 Data Of IPI-145 In Indolent Non-Hodgkin Lymphoma At ASH Annual Meeting
2013-12-07,Infinity Reports Preclinical Data At ASH Annual Meeting In Diffuse Large B-Cell Lymphoma And T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential Of IPI-145 In Blood Cancers
2013-12-06,Infinity To Present At The Oppenheimer 24th Annual Healthcare Conference
2013-11-15,5 Stocks Poised for Breakouts
2013-11-11,Infinity Announces New Date And Time For Credit Suisse 2013 Healthcare Conference Presentation And Webcast
2013-11-07,Infinity Reports Third Quarter 2013 Financial Results And Provides Company Update
2013-11-07,Infinity Announces Clinical And Preclincial Data To Be Presented At ASH 2013 Annual Meeting
2013-11-06,Infinity To Participate In Three Upcoming Conferences
2013-10-30,RSI Alert: Infinity Pharmaceuticals (INFI) Now Oversold
2013-10-24,Infinity Announces The Date Of Its Third Quarter 2013 Financial Results Conference Call And Webcast
2013-10-16,Bulls Bet Infinity Pharma Will Rebound
2013-10-08,RSI Alert For Infinity Pharmaceuticals (INFI)
2013-09-25,Infinity Reports Topline Data From Phase 2 Study Of Retaspimycin Hydrochloride, Its Hsp90 Inhibitor, In Patients With Non-Small Cell Lung Cancer
2013-09-16,Julian Adams, Ph.D., Of Infinity Pharmaceuticals Named Corporate Chair For The Leukemia &amp; Lymphoma Society&#8217;s Light The Night Walk
2013-09-04,Infinity Expands Executive Leadership Team, Appointing David A. Roth As Senior Vice President, Clinical Development And Medical Affairs
2013-09-03,Infinity Supports Blood Cancer Awareness Month With Launch Of Sparks Of Inspiration, A Campaign To Honor People Affected By Blood Cancer
2013-08-27,Infinity To Participate In Three Conferences In September
2013-08-08,Infinity Reports Second Quarter 2013 Financial Results And Provides Company Update
2013-08-06,5 Stocks Poised to Pop on Bullish Earnings
2013-08-01,Infinity Announces The Date Of Its Second Quarter 2013 Financial Results Conference Call And Webcast
